Temporal Trends in Use of Sildenafil among Pediatric Patients

被引：4

作者：

Bhutta, Adnan T. ^{[1
,2
]}

Beam, Brandon ^{[1
,2
]}

Prodhan, Parthak ^{[1
,2
]}

机构：

[1] Univ Arkansas Med Sci, Little Rock, AR 72205 USA

[2] Arkansas Childrens Hosp, Little Rock, AR 72202 USA

来源：

关键词：

PULMONARY ARTERIAL-HYPERTENSION;

D O I：

10.1164/rccm.201301-0159LE

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1269 / 1271

页数：3

共 6 条

[1] Implications of the U.S. Food and Drug Administration Warning against the Use of Sildenafil for the Treatment of Pediatric Pulmonary Hypertension
Abman, Steven H.
Kinsella, John P.
Rosenzweig, Erika B.
Krishnan, Usha
Kulik, Thomas
Mullen, Mary
Wessel, David L.
Steinhorn, Robin
Adatia, Ian
Hanna, Brian
Feinstein, Jeffrey
Fineman, Jeffrey
Raj, Usha
Humpl, Tilman
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187 (06) : 572 - 575
[2] [Anonymous], 2015, FDA Drug Safety Communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood
[3] Barst RJ, 2012, EUR HEART J, V33, P979
[4] A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension
Barst, Robyn J.
Ivy, D. Dunbar
Gaitan, Guillermo
Szatmari, Andras
Rudzinski, Andrzej
Garcia, Alberto E.
Sastry, B. K. S.
Pulido, Tomas
Layton, Gary R.
Serdarevic-Pehar, Marjana
Wessel, David L.
[J]. CIRCULATION, 2012, 125 (02) : 324 - 334
[5] Child Health Corporation of America, 2012, OWN HOSP
[6] European Medicines Agency, EPAR SUMM PUBL REV